EPHA2 and breast cancer: Similarly, Anderton et al. reported that EPHA2/-B4 represent the main oncogenic EPHs in BC, with other members of the EPH family also showing up- or downregulation in BC, and evidently exhibiting either tumor-promoting or tumor-suppressing capacities [21].